496 related articles for article (PubMed ID: 8476211)
1. NK cells from mammary tumor bearing mice do not exert natural killer activity but function as antibody dependent cellular cytotoxicity effectors.
Rivera LM; Lopez DM
Anticancer Res; 1993; 13(1):177-84. PubMed ID: 8476211
[TBL] [Abstract][Full Text] [Related]
2. Soluble and membrane-bound TNF-alpha are involved in the cytotoxic activity of B cells from tumor-bearing mice against tumor targets.
Lopez-Cepero M; Garcia-Sanz JA; Herbert L; Riley R; Handel ME; Podack ER; Lopez DM
J Immunol; 1994 Apr; 152(7):3333-41. PubMed ID: 8144919
[TBL] [Abstract][Full Text] [Related]
3. Thymic involution and thymocyte phenotypic alterations induced by murine mammary adenocarcinomas.
Fu Y; Paul RD; Wang Y; Lopez DM
J Immunol; 1989 Dec; 143(12):4300-7. PubMed ID: 2592775
[TBL] [Abstract][Full Text] [Related]
4. Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection.
Stein-Streilein J; Bennett M; Mann D; Kumar V
J Immunol; 1983 Dec; 131(6):2699-704. PubMed ID: 6644021
[TBL] [Abstract][Full Text] [Related]
5. Modulation of murine natural killer cells by a granulocytosis-inducing tumor.
Pollack SB; Lee MY; Cohen E; Lottsfeldt JL; Rosse C
Cancer Res; 1989 Jan; 49(1):174-8. PubMed ID: 2908844
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of natural killer cell numbers but not function in leukemic infant mice: a system primed in infancy allows survival in adulthood.
Dussault I; Miller SC
Nat Immun; 1993; 12(2):66-78. PubMed ID: 8318817
[TBL] [Abstract][Full Text] [Related]
8. Triggering of the cytotoxic activity of murine natural killer and lymphokine-activated killer cells through the NK2.1 antigen.
Morelli L; Lemieux S
J Immunol; 1993 Dec; 151(12):6783-93. PubMed ID: 8258690
[TBL] [Abstract][Full Text] [Related]
9. Identity of effector cells participating in the reverse antibody-dependent cell-mediated cytotoxicity.
Saxena RK; Saxena QB; Adler WH
Immunology; 1982 Jun; 46(2):459-64. PubMed ID: 7084998
[TBL] [Abstract][Full Text] [Related]
10. Antibody-dependent natural killer cell-mediated cytotoxicity engendered by a kinase-inactive human HER2 adenovirus-based vaccination mediates resistance to breast tumors.
Triulzi C; Vertuani S; Curcio C; Antognoli A; Seibt J; Akusjärvi G; Wei WZ; Cavallo F; Kiessling R
Cancer Res; 2010 Oct; 70(19):7431-41. PubMed ID: 20823150
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin-2.
Hinuma S; Naruo K; Shiho O; Tsukamoto K
Immunology; 1986 Oct; 59(2):251-9. PubMed ID: 3490435
[TBL] [Abstract][Full Text] [Related]
12. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). I. Proliferative response and establishment of cloned cells.
Suzuki R; Handa K; Itoh K; Kumagai K
J Immunol; 1983 Feb; 130(2):981-7. PubMed ID: 6600260
[TBL] [Abstract][Full Text] [Related]
13. Origin and differentiation of natural killer cells. II. Functional and morphologic studies of purified NK-1.1+ cells.
Hackett J; Tutt M; Lipscomb M; Bennett M; Koo G; Kumar V
J Immunol; 1986 Apr; 136(8):3124-31. PubMed ID: 3958492
[TBL] [Abstract][Full Text] [Related]
14. Emergence of a B lymphocyte population with ADCC effector function in mammary tumor bearing mice.
Padmanabhan RR; Paul RD; Watson GA; Lopez DM
J Leukoc Biol; 1988 Jun; 43(6):509-19. PubMed ID: 3259973
[TBL] [Abstract][Full Text] [Related]
15. Immunologic control of a retrovirus-associated murine adenocarcinoma. VIII. Corynebacterium parvum-activated natural killer cells as potent antibody-dependent cell-mediated cytotoxicity effectors.
Weinhold KJ; Bolognesi DP; Matthews TJ
J Natl Cancer Inst; 1985 Oct; 75(4):717-24. PubMed ID: 3862904
[TBL] [Abstract][Full Text] [Related]
16. Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. II. Characterization of the effector cells.
Santoni A; Herberman RB; Holden HT
J Natl Cancer Inst; 1979 Oct; 63(4):995-1003. PubMed ID: 384012
[TBL] [Abstract][Full Text] [Related]
17. Expression of asialo GM1 and other antigens and glycolipids on natural killer cells and spleen leukocytes in virus-infected mice.
Yang H; Yogeeswaran G; Bukowski JF; Welsh RM
Nat Immun Cell Growth Regul; 1985; 4(1):21-39. PubMed ID: 3875791
[TBL] [Abstract][Full Text] [Related]
18. Splenocyte natural killer cell activity and metastatic potential are inversely dependent on estrous stage.
Gruber SA; Hoffman RA; Sothern RB; Lakatua D; Carlson A; Simmons RL; Hrushesky WJ
Surgery; 1988 Aug; 104(2):398-403. PubMed ID: 3261050
[TBL] [Abstract][Full Text] [Related]
19. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
Muralikrishna K; Varalakshmi C; Khar A
Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
[TBL] [Abstract][Full Text] [Related]
20. Enhanced natural killer cell binding and activation by low-fucose IgG1 antibody results in potent antibody-dependent cellular cytotoxicity induction at lower antigen density.
Niwa R; Sakurada M; Kobayashi Y; Uehara A; Matsushima K; Ueda R; Nakamura K; Shitara K
Clin Cancer Res; 2005 Mar; 11(6):2327-36. PubMed ID: 15788684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]